Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD Source: Eur Respir J 2016; 47: 651-654 Year: 2016
Rapid and sustained improvements in lung function and symptom control with budesonide/formoterol in adolescent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 494s Year: 2001
Predictors of accelerated decline in lung function in adult-onset asthma Source: Eur Respir J, 51 (2) 1701785; 10.1183/13993003.01785-2017 Year: 2018
Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019
Estimating lung function decline and the effect of smoking in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 578s Year: 2002
Omalizumab improves asthma control in patients receiving high-dose ICS and multiple other controller therapies and who have continuing impairment of lung function and asthma symptoms Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007
Early health status improvements decline after LVRS despite persistent reduction in lung volume Source: Eur Respir J 2002; 20: Suppl. 38, 607s Year: 2002
Predictors of lung function deterioration in COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
The effects of early intervention with inhaled budesonide on lung function in mild persistent asthma: results from the START study Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003
Lung function decline in long-term follow-up of bronchial asthma Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010
Improvement of lung function after a 6-week placebo controlled budesonide treatment in symptomatic infants with decreased airways conductance Source: Eur Respir J 2004; 24: Suppl. 48, 157s Year: 2004
Predicting an accelerated lung function decline in smokers: is there a proper threshold? Source: Eur Respir J 2014; 43: 308-309 Year: 2004
Predicting an accelerated lung function decline in smokers: is there a proper threshold? Source: Eur Respir J 2014; 43: 307-308 Year: 2004
Which lung function variables are the most sensitive to a short bronchodilator in COPD patients? Source: Annual Congress 2008 - Quality spirometry: the only spirometry! Year: 2008
Postponed fluticasone propionate treatment in subjects with a rapid decline in lung function. Results of the DIMCA program Source: Eur Respir J 2002; 20: Suppl. 38, 414s Year: 2002
Pre-treatment lung function decline stabilizes up to 3 year after targeted lung denervation in COPD Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology Year: 2020
Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001
Pulmonary function test changes after cessation of inhaled corticosteroid therapy in asthma patients Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012
Smoking, sputum cell counts, diffusion capacity and hyperinflation predict beneficial effects of long-term inhaled corticosteroids (ICS) on FEV1-decline in patients with mild-to-moderate COPD Source: Annual Congress 2010 - COPD: management Year: 2010